Canada Nuclear Medicine Radioisotopes Market (2025-2031) | Companies, Analysis, Share, Forecast, Value, Size, Trends, Outlook, Growth, Revenue, Segmentation & Industry

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Canada Country Macro Economic Indicators

3.2 Canada Nuclear Medicine Radioisotopes Market Revenues & Volume, 2021 & 2031F

3.3 Canada Nuclear Medicine Radioisotopes Market - Industry Life Cycle

3.4 Canada Nuclear Medicine Radioisotopes Market - Porter's Five Forces

3.5 Canada Nuclear Medicine Radioisotopes Market Revenues & Volume Share, By Types, 2021 & 2031F

3.6 Canada Nuclear Medicine Radioisotopes Market Revenues & Volume Share, By Application, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer and cardiovascular diseases driving the demand for nuclear medicine procedures.

4.2.2 Technological advancements leading to the development of new radioisotopes for diagnostic and therapeutic applications.

4.2.3 Growing awareness and acceptance of nuclear medicine among healthcare professionals and patients.

4.3 Market Restraints

4.3.1 Regulatory challenges and stringent government policies regarding the use and transportation of radioisotopes.

4.3.2 High cost associated with the production and maintenance of nuclear medicine facilities.

4.3.3 Limited availability of skilled professionals in the field of nuclear medicine.

6.1 Canada Nuclear Medicine Radioisotopes Market, By Types

6.1.1 Overview and Analysis

6.1.2 Canada Nuclear Medicine Radioisotopes Market Revenues & Volume, By Technetium-99m (Tc-99m), 2021-2031F

6.1.3 Canada Nuclear Medicine Radioisotopes Market Revenues & Volume, By Thallium-201 (Tl-201), 2021-2031F

6.1.4 Canada Nuclear Medicine Radioisotopes Market Revenues & Volume, By Iodine (I-123), 2021-2031F

6.1.5 Canada Nuclear Medicine Radioisotopes Market Revenues & Volume, By Fluorine-18, 2021-2031F

6.1.6 Canada Nuclear Medicine Radioisotopes Market Revenues & Volume, By Rubidium-82 (Rb-82), 2021-2031F

6.1.7 Canada Nuclear Medicine Radioisotopes Market Revenues & Volume, By Iodine-131 (I-131), 2021-2031F

6.1.9 Canada Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2021-2031F

6.1.10 Canada Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2021-2031F

6.2 Canada Nuclear Medicine Radioisotopes Market, By Application

6.2.1 Overview and Analysis

6.2.2 Canada Nuclear Medicine Radioisotopes Market Revenues & Volume, By Oncology, 2021-2031F

6.2.3 Canada Nuclear Medicine Radioisotopes Market Revenues & Volume, By Cardiology, 2021-2031F

6.2.4 Canada Nuclear Medicine Radioisotopes Market Revenues & Volume, By Thyroid, 2021-2031F

6.2.5 Canada Nuclear Medicine Radioisotopes Market Revenues & Volume, By Neurology, 2021-2031F

6.2.6 Canada Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2021-2031F

7.1 Canada Nuclear Medicine Radioisotopes Market Export to Major Countries

7.2 Canada Nuclear Medicine Radioisotopes Market Imports from Major Countries

8.1 Patient wait times for nuclear medicine procedures, indicating the efficiency of healthcare facilities in providing timely services.

8.2 Number of research collaborations between academic institutions and industry for the development of new radioisotopes, reflecting innovation in the market.

8.3 Rate of adoption of nuclear medicine technologies in different healthcare settings, showing the acceptance and integration of these technologies in clinical practice.

9.1 Canada Nuclear Medicine Radioisotopes Market Opportunity Assessment, By Types, 2021 & 2031F

9.2 Canada Nuclear Medicine Radioisotopes Market Opportunity Assessment, By Application, 2021 & 2031F

10.1 Canada Nuclear Medicine Radioisotopes Market Revenue Share, By Companies, 2024

10.2 Canada Nuclear Medicine Radioisotopes Market Competitive Benchmarking, By Operating and Technical Parameters